ANA GUERRERO: Open Payments
NPI 1629564307 · GEORGETOWN, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$543 in 14 payments from 8 companies in 2025. Trend: 2023 $417 · 2024 $337 · 2025 $543
Food & beverage: $442Education: $101
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 1 | $125 |
| Teva Pharmaceuticals USA, Inc. | 2 | $120 |
| Alnylam Pharmaceuticals Inc. | 1 | $120 |
| Neurocrine BioSciences, Inc. | 5 | $97 |
| Vanda Pharmaceuticals Inc. | 2 | $30 |
| Lilly USA, LLC | 1 | $18 |
| Exact Sciences Corporation | 1 | $17 |
| Novo Nordisk Inc | 1 | $15 |
Products named: ABILIFY MAINTENA, AMVUTTRA, INGREZZA, AUSTEDO XR, MOUNJARO, The Cologuard Plus Collection Kit, HETLIOZ, FANAPT.
Industry payments across DE — which companies pay providers there.
